SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028309
Filing Date
2018-11-08
Accepted
2018-11-08 08:34:07
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20180930.htm 10-Q 1357178
2 EX-31.1 elox-ex311_8.htm EX-31.1 8609
3 EX-31.2 elox-ex312_6.htm EX-31.2 9066
4 EX-32.1 elox-ex321_7.htm EX-32.1 6850
5 EX-32.2 elox-ex322_9.htm EX-32.2 6687
  Complete submission text file 0001564590-18-028309.txt   5518438

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elox-20180930.xml EX-101.INS 1223166
7 XBRL TAXONOMY EXTENSION SCHEMA elox-20180930.xsd EX-101.SCH 46513
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20180930_cal.xml EX-101.CAL 31590
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20180930_def.xml EX-101.DEF 151365
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20180930_lab.xml EX-101.LAB 322959
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20180930_pre.xml EX-101.PRE 266435
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 181168305
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services